InvestorsHub Logo
Followers 65
Posts 23938
Boards Moderated 0
Alias Born 11/23/2016

Re: WolfofMia post# 362749

Thursday, 06/09/2022 7:31:25 AM

Thursday, June 09, 2022 7:31:25 AM

Post# of 462890
Be interesting to see how Biogen/Eisai go about lecanemab.

Their "Innovative Bayesian Adaptive Randomization Design and Dose Regimen-Finding Study with OLE", probably has designed in wriggle room.

They claim "Rapid and Thorough Amyloid Clearance Correlates with Clinical Benefit", but one can have doubts.

Will they lay down flat this time on a dubious readout or have another 'oh wait a minute there is actually a perspective from which the drug does work' moment?

LATEST FINDINGS ON LECANEMAB
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News